News

targets for mabs - innovative approaches for their discovery and validation

AIS 2018 : TARGETS FOR MABS INNOVATIVE APPROACHES FOR THEIR DISCOVERY & VALIDATION

Read more

master class immunotherapie

MASTER CLASSES DE L’IMMUNOTHÉRAPIE

Read more

Development of new immunoconjugates for HER2-positive breast cancers

Read more

bandeau carré AIS2017 1

Assises 2017: Antibody-Drug Conjugates

Read more

Bioterrorisme : un traitement contre l’empoisonnement à la ricine – Le Magazine de la santé

Read more

2 Years Post-doctoral fellowship in Montpellier

Read more

Allocations doctorales 2016 : Listes des sujets de thèses anticorps

Read more

Recherche

First-in-­human phase I study for SurgiMab’s molecule SGM-­101 launched in Montpellier Cancer Institute.

Read more

MAbDelivery Industrial Workshop

Read more

PhD Projects 2015

Read more

Call for proposals 2015: New research team & group leader

Read more

PhD Project 2014 “Design of a method for in silico maturation of antibodies”

Read more